Transition Mutation
Exit Strategy: Biopharma Professionals Consider Opportunities Outside Industry and US
biopharma talent; job market trends; industry transition; employment outside US; biopharma survey 2025; life sciences employment; biotech careers; pharmaceutical industry
UnitedHealth Group CEO Andrew Witty Steps Down; Stephen Hemsley Returns as CEO
UnitedHealth Group; Andrew Witty; Stephen Hemsley; CEO transition; leadership change; personal reasons; financial guidance suspension; stock drop
Nimbus Therapeutics Announces Leadership Transition: Abbas Kazimi Appointed as New CEO
Nimbus Therapeutics, CEO transition, Abbas Kazimi, Jeb Keiper, biotechnology, computational drug discovery
Julie Kim to Succeed Christophe Weber as Takeda’s CEO in 2026
Takeda, Julie Kim, Christophe Weber, CEO succession, pharmaceutical industry, leadership transition, biopharmaceutical company
Metsera and Amneal Collaborate on Next-Generation Obesity Medicines, with Leadership Transition at Metsera
Metsera, Amneal, Obesity Drugs, Strategic Collaboration, Manufacturing Partnership, Leadership Transition
Amarin Names New CEO Aaron Berg Following Patrick Holt’s Resignation
Amarin, CEO, Patrick Holt, Aaron Berg, Resignation, Leadership Transition
AbbVie CEO Gonzalez to Step Down, Robert Michael named Successor in Seamless Transition
Gonzalez, AbbVie’s, company’s, Transition Mutation